Taking a migraine and epilepsy drug known as topiramate by pregnant women can increase the risk of developing oral birth defects in the unborn, US federal agency warns.
The Food and Drug Administration (FDA) announced that expectant mothers who use topiramate (Topamax) are about 20 times more likely to have their infants develop cleft lips or cleft palate deformities.
No comments:
Post a Comment